Digoxin Immune Fab labels and packages: Difference between revisions

Jump to navigation Jump to search
Abdurahman Khalil (talk | contribs)
No edit summary
Abdurahman Khalil (talk | contribs)
No edit summary
Line 7: Line 7:
Manufactured by:                Protherics Inc. Brentwood, TN 37027  
Manufactured by:                Protherics Inc. Brentwood, TN 37027  


Distributed by:                    E. FOUGERA & CO. and Savage Laboratories®  
Distributed by:                    E. FOUGERA & CO. and Savage Laboratories® both divisions of Nycomed US Inc., Melville, NY 11747  
                                              both divisions of Nycomed US Inc., Melville, NY 11747  


U.S. License No.                1575  
U.S. License No.                1575  

Revision as of 17:12, 27 February 2014

Digoxin Immune Fab
DIGIFAB® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Digoxin Immune Fab
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

For patient information about Digoxin immune fab, click here.

Manufactured by: Protherics Inc. Brentwood, TN 37027

Distributed by: E. FOUGERA & CO. and Savage Laboratories® both divisions of Nycomed US Inc., Melville, NY 11747

U.S. License No. 1575

Revised: July 2008 IF7036510B

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 40 mg CONTAINER LABEL NDC 0281-0365-10

Digoxin Immune Fab (Ovine) Digifab®

40 mg

Rx Only


References

http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6832767f-db6b-4eea-b88b-bdfc905749e1